Determining Exercise Tolerance using an EMG Cycle Test in patients with a neuromuscular disorder

Determining Exercise Tolerance using an EMG Cycle Test in patients with a neuromuscular disorder - DETECT-NMD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48098

Enrollment

Registered

2019-03-21

Start date

2019-03-21

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

muscle diseases neuromuscular disorders

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - aged 18 years and older - being able to read and understand the Dutch language - mentally competent - being able to cycle at least 8 minutes on a cycle leg and/ or arm ergometer

Exclusion criteria

Exclusion criteria: - pregnancy - cognitive impairment - disabling co-morbidity interfering with the cycle test - contraindications to Exercise Stress Testing according to the guidelines of the American Heart Association

Design outcomes

Primary

Measure	Time frame
sEMG amplitude sEMG median frequency	—

Secondary

Measure	Time frame
3D movement analysis spirometry (VO2 max, heart rate, anaerobic threshold, workolad, serum lactate levels, Borg scale) Muscle strength	—

Countries

Netherlands

Outcome results